DYN Logo

Dyne Therapeutics, Inc. (DYN) 

NASDAQ
Market Cap
$2.44B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
17 of 960
Rank in Industry
13 of 550

Largest Insider Buys in Sector

DYN Stock Price History Chart

DYN Stock Performance

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..

Insider Activity of Dyne Therapeutics, Inc.

Over the last 12 months, insiders at Dyne Therapeutics, Inc. have bought $30.26M and sold $229.52M worth of Dyne Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Dyne Therapeutics, Inc. have bought $30.53M and sold $59.11M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kersten Dirk () — $30M. Cox John (CEO & President) — $792,912.

The last purchase of 8,000 shares for transaction amount of $264,304 was made by Cox John (CEO & President) on 2024‑09‑04.

List of Insider Buy and Sell Transactions, Dyne Therapeutics, Inc.

2024-12-11SaleChief Scientific Officer
2,334
0.0023%
$28.12$65,632-6.33%
2024-12-11SaleSVP, Head of Finance & Admin.
1,455
0.0015%
$28.12$40,915-6.33%
2024-12-09Saledirector
34,437
0.0341%
$29.18$1M-8.96%
2024-12-06Saledirector
101,675
0.0994%
$29.34$2.98M-11.42%
2024-12-05Saledirector
3,806
0.0039%
$29.05$110,564-5.70%
2024-12-04Saledirector
135,039
0.133%
$29.39$3.97M-8.92%
2024-12-03Saledirector
29,732
0.0299%
$29.05$863,715-2.48%
2024-12-02Saledirector
81,201
0.0802%
$29.67$2.41M-5.72%
2024-11-18SaleChief Scientific Officer
2,856
0.0026%
$28.20$80,539-0.37%
2024-11-18SaleSVP, Head of Finance & Admin.
2,735
0.0025%
$28.20$77,127-0.37%
2024-11-18Saledirector
16,500
0.0152%
$28.73$474,045-0.37%
2024-11-14Saledirector
8,929
0.0094%
$32.82$293,050-3.56%
2024-11-14Saledirector
782
0.0008%
$33.10$25,884-3.56%
2024-11-13Saledirector
10,803
0.0122%
$35.24$380,698-14.28%
2024-10-21Saledirector
121
0.0001%
$35.06$4,242-12.54%
2024-10-18Saledirector
13,414
0.0151%
$35.16$471,636-16.84%
2024-10-17Saledirector
13,013
0.0147%
$35.17$457,667-15.55%
2024-10-16Saledirector
23,671
0.0269%
$35.35$836,770-17.13%
2024-10-02Saledirector
21,518
0.0244%
$35.38$761,307-16.50%
2024-10-01Saledirector
8,423
0.0095%
$35.16$296,153-14.59%

Insider Historical Profitability

<0.0001%
Kersten Dirkdirector
5400545
5.3068%
$23.99342
Rhodes Jason Pdirector
15962
0.0157%
$23.99111<0.0001%
Cox JohnCEO & President
8000
0.0079%
$23.9910
Litespeed Management, L.L.C.10 percent owner
28507291
28.0126%
$23.99190
VV Manager II, LLC10 percent owner
2880125
2.8301%
$23.9910<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.